What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Year 2025 Referencia J Control Release. 2025 Mar 10:113616. doi: 10.1016/j.jconrel.2025.113616. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.jconrel.2025.113616 Revista JOURNAL OF CONTROLLED RELEASE Títol Complet Preclinical evaluation of several polymeric micelles identifies Soluplus(R)-docetaxel as the most effective candidate in multiple glioblastoma models. Codi 75255 PMID https://pubmed.ncbi.nlm.nih.gov/40073942 Nom Autors Abasolo, Ibane; Alcina, Angels; Andrade, Fernanda; Campos-Moreno, Sofia; Costa, Roser Ferrer; Diaz-Riascos, Zamira V; Fischer-Albiol, Narine; Garcia, Belen; German-Cortes, Julia; Herrero, Raquel et al. DOI número 10.1016/j.jconrel.2025.113616 Year 2025 Referencia Med Image Anal. 2025 Mar 7;102:103531. doi: 10.1016/j.media.2025.103531. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.media.2025.103531 Revista MEDICAL IMAGE ANALYSIS Títol Complet SpinFlowSim: A blood flow simulation framework for histology-informed diffusion MRI microvasculature mapping in cancer. Autors Manuel Escobar Amores Nuria Roson Gradaille Codi 75256 PMID https://pubmed.ncbi.nlm.nih.gov/40073583 Nom Autors Bernatowicz, Kinga; Escobar, Manuel; Fieremans, Els; Garralda, Elena; Grigoriou, Athanasios; Grussu, Francesco; Novikov, Dmitry S; Nuciforo, Paolo; Palombo, Marco; Perez-Lopez, Raquel et al. DOI número 10.1016/j.media.2025.103531 Year 2025 Títol Complet servicio de un gerente de ensayos clínicos para el proyecto “Investigación operativa contra la desnutrición infantil crónica en Angola” (Proyecto CRESCER)-FED/2020/418-106 de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient GERENTE DE ENSAYOS CLÍNICOS PROYECTO CRESCER Codi 24980241 Data publicació Wed, 5 Mar 2025 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP (word) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC INFORME DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT Year 2025 Títol Complet Hiring a service of DNA and RNA sequencing and data analysis from tumor samples and whole blood in the Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR) Expedient RNA SEQUENCING (PI23/01045) Codi 24980240 Data publicació Wed, 5 Mar 2025 - 12:00 Documentos (enllaços) TENDER NOTICE SPECIFIC ADMINISTRATIVE BIDDING CONDITIONS APPENDIX 1 PCAP DOCUMENT OF TECHNICAL SPECIFICATIONS MAIN POINTS ON THE DIGITAL TOOL DEUC DEUC XML. INSTRUCTIONS FOR FILLING DEUC AGREEMENT ON THE NEED SUFFICIENCY OF CREDIT CERTIFICATE RESOLUTION ON THE APPOINTMENT OF THE CONTRACT AWARDING COMMITTEE RESOLUTION FOR THE APPROVAL OF THE TENDER TECHNICAL EVALUATION REPORT RESOLUTION DESERT Year 2025 Títol Complet Servei extern per la logística de la gestió dels kits d'assaigs clínics per la Unitat de Suport a la Investigació Clínica de la Fundació Hospital Universitari Vall Hebron – Institut de Recerca (VHIR). Expedient GESTIÓ KITS DEL ASSAIGS CLÍNICS Codi 24980239 Data publicació Wed, 5 Mar 2025 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP (word) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC INFORME DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT INFORME DE VALORACIÓ TÉCNICA Professionals Laura Ludovica Gramegna . Professionals Carlos Mauricio Larrarte King Professionals Xana Garcia Fernandez I am a Biology graduate with a special interest in neglected and parasitic infectious diseases. I am part of the Diagnostic Nanotools group (DINA) at the Vall d'Hebron Research Institute, where we work on the development of new diagnostic techniques for infectious diseases. Professionals Marta Fernandez Lobera Professionals Belen Alvarez Palomo A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients with Multiple System Atrophy Contact Protocol code: TV56286-NDG-20039 EudraCT code: No aplica Pathology: Malalties del sistema nerviós Principal investigator: Hernández Vara, Jorge Research group: Malalties neurodegeneratives Service: Neurologia Phase: Fase II Recruiting: Closed Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio multicéntrico, aleatorizado, doble ciego, controlado con placebo y degrupos paralelos para evaluar la eficacia y la seguridad de dapirolizumab pegol en participantes del estudio con lupus eritematoso sistémico de moderado a grave Contact Protocol code: SL0044 EudraCT code: 2019-003407-35 Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Cortes Hernandez, Josefina Research group: Reumatologia Service: Reumatologia Phase: Fase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio Fase 2b, multicéntrico, aleatorizado, parcialmentecontrolado con placebo y doble ciego para evaluar la seguridad y eficacia de laadministración secuencial de Daplusiran/Tomligisiran seguido de bepirovirsen enparticipantes con Hepatitis B crónica en tratamiento con análogos de nucleós(t)idos (BUnited). Contact Protocol code: 218309 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Buti Ferret, Maria Research group: Malalties hepàtiques Service: Hepatologia Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. An open label complex clinical trial in newly diagnosed pediatric de novo AML patients – a study by the NOPHO-DB-SHIP consortium Contact Protocol code: CHIP-AML22/Master EudraCT code: No aplica Pathology: Tumors Principal investigator: Murillo Sanjuán , Laura Research group: Càncer i malalties hematològiques infantils Service: Oncohematologia Pediàtrica Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ESTUDIO EN FASE IB MULTICÉNTRICO, NO ALEATORIZADO,ABIERTO, ADAPTATIVO, CON GRUPOS PARALELOS, DE DOSIS ÚNICAS ASCENDENTES(PARTES 1 Y 2) Y DOSIS MÚLTIPLES ASCENDENTES (PARTE 3) PARA INVESTIGAR LASEGURIDAD, TOLERABILIDAD, INMUNOGENICIDAD, FARMACOCINÉTICA YFARMACODINAMIA DE RO7121932 TRAS ADMINISTRACIÓN POR VÍA INTRAVENOSA(PARTE 1) Y SUBCUTÁNEA (PARTES 2 Y 3) EN PARTICIPANTES CON ESCLEROSISMÚLTIPLE Contact Protocol code: BP42230 EudraCT code: 2020-004122-33 Pathology: Nervous system diseases Principal investigator: Montalban Gairín, Xavier Research group: Neuroimmunologia clínica Service: Neuroimmunologia Phase: Fase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Un ensayo multicéntrico, aleatorizado y doble ciego para evaluar laeficacia y la seguridad de PRAX-628 en adultos con crisis focales (POWER 1) Contact Protocol code: PRAX-628-321 EudraCT code: No aplica Pathology: Tumors Principal investigator: Toledo Argany, Manuel Research group: Grup de recerca de l'estat epilèptic i crisis agudes Service: Neurology Phase: Phase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Optimization of albuminuria lowering therapies to individual patients with CKD using FINErenone and SEmaglutide. Contact Protocol code: 17456 (FINESSE) EudraCT code: _ Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Soler Romeo, Maria Jose Research group: Nefrologia i trasplantament renal Service: Nefrologia Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. ENSAYO EN FASE Ib EN CANASTA SIN ENMASCARAMIENTO DE RAY121 PARA INHIBIR LA VÍA CLÁSICA DEL COMPLEMENTO EN ENFERMEDADES INMUNOLÓGICAS Contact Protocol code: RAY902CT EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Pardos Gea, José Research group: Malalties sistèmiques Service: Medicina Interna Phase: Phase I Recruiting: Closed Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. PROLONGACIÓN DEL BESTOW: Estudio en fase II, multicéntrico, sinenmascaramiento y de prolongación para evaluar la seguridad y eficacia a largo plazo de tegoprubarten receptores de trasplante de riñón Contact Protocol code: AT-1501-K209 EudraCT code: No aplica Pathology: Symptoms, signs, and abnormal clinical and laboratory findings, not elsewhere classified Principal investigator: Bestard Matamoros, Oriol Research group: Nephrology and kidney transplantation Service: Nephrology Phase: Phase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio en fase 1/2 de determinación de la dosis y ampliación de la dosis de Cobolimab en combinación con Dostarlimab en participantes pediátricos y adultos jóvenes con tumores recién diagnosticados y recidivantes/resistentes al tratamiento Contact Protocol code: 219451 EudraCT code: No aplica Pathology: Tumors Principal investigator: Valero Arrese, Lorena Research group: Childhood Cancer and Blood Disorders Service: Pediatric Oncohematology Phase: Phase I Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Pagination First page « Previous page ‹ … Page 1408 Page 1409 Current page 1410 Page 1411 Page 1412 … Next page › Last page »
Year 2025 Referencia J Control Release. 2025 Mar 10:113616. doi: 10.1016/j.jconrel.2025.113616. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.jconrel.2025.113616 Revista JOURNAL OF CONTROLLED RELEASE Títol Complet Preclinical evaluation of several polymeric micelles identifies Soluplus(R)-docetaxel as the most effective candidate in multiple glioblastoma models. Codi 75255 PMID https://pubmed.ncbi.nlm.nih.gov/40073942 Nom Autors Abasolo, Ibane; Alcina, Angels; Andrade, Fernanda; Campos-Moreno, Sofia; Costa, Roser Ferrer; Diaz-Riascos, Zamira V; Fischer-Albiol, Narine; Garcia, Belen; German-Cortes, Julia; Herrero, Raquel et al. DOI número 10.1016/j.jconrel.2025.113616
Year 2025 Referencia Med Image Anal. 2025 Mar 7;102:103531. doi: 10.1016/j.media.2025.103531. Tipus publicació Paper in international publication DOI http://dx.doi.org/10.1016/j.media.2025.103531 Revista MEDICAL IMAGE ANALYSIS Títol Complet SpinFlowSim: A blood flow simulation framework for histology-informed diffusion MRI microvasculature mapping in cancer. Autors Manuel Escobar Amores Nuria Roson Gradaille Codi 75256 PMID https://pubmed.ncbi.nlm.nih.gov/40073583 Nom Autors Bernatowicz, Kinga; Escobar, Manuel; Fieremans, Els; Garralda, Elena; Grigoriou, Athanasios; Grussu, Francesco; Novikov, Dmitry S; Nuciforo, Paolo; Palombo, Marco; Perez-Lopez, Raquel et al. DOI número 10.1016/j.media.2025.103531
Year 2025 Títol Complet servicio de un gerente de ensayos clínicos para el proyecto “Investigación operativa contra la desnutrición infantil crónica en Angola” (Proyecto CRESCER)-FED/2020/418-106 de la Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR). Expedient GERENTE DE ENSAYOS CLÍNICOS PROYECTO CRESCER Codi 24980241 Data publicació Wed, 5 Mar 2025 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP (word) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC INFORME DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT
Year 2025 Títol Complet Hiring a service of DNA and RNA sequencing and data analysis from tumor samples and whole blood in the Fundació Hospital Universitari Vall Hebron - Institut de Recerca (VHIR) Expedient RNA SEQUENCING (PI23/01045) Codi 24980240 Data publicació Wed, 5 Mar 2025 - 12:00 Documentos (enllaços) TENDER NOTICE SPECIFIC ADMINISTRATIVE BIDDING CONDITIONS APPENDIX 1 PCAP DOCUMENT OF TECHNICAL SPECIFICATIONS MAIN POINTS ON THE DIGITAL TOOL DEUC DEUC XML. INSTRUCTIONS FOR FILLING DEUC AGREEMENT ON THE NEED SUFFICIENCY OF CREDIT CERTIFICATE RESOLUTION ON THE APPOINTMENT OF THE CONTRACT AWARDING COMMITTEE RESOLUTION FOR THE APPROVAL OF THE TENDER TECHNICAL EVALUATION REPORT RESOLUTION DESERT
Year 2025 Títol Complet Servei extern per la logística de la gestió dels kits d'assaigs clínics per la Unitat de Suport a la Investigació Clínica de la Fundació Hospital Universitari Vall Hebron – Institut de Recerca (VHIR). Expedient GESTIÓ KITS DEL ASSAIGS CLÍNICS Codi 24980239 Data publicació Wed, 5 Mar 2025 - 12:00 Documentos (enllaços) ANUNCI DE LICITACIÓ PLEC DE CLÀUSULES ADMINISTRATIVES PARTICULARS ANNEX 1 PCAP (word) PLEC DE PRESCRIPCIONS TÈCNIQUES PRINCIPALS PUNTS SOBRE DIGITAL DEUC DEUC FORMAT XML INSTRUCCIONS PER EMPLENAR EL DEUC INFORME DE NECESSITAT CERTIFICAT D'EXISTÈNCIA DE CRÈDIT RESOLUCIÓ DESIGNACIÓ DE LA MESA DE CONTRACTACIÓ RESOLUCIÓ D'APROVACIÓ DE L'EXPEDIENT INFORME DE VALORACIÓ TÉCNICA
